| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.48B | $1.45B | $1.69B |
| YoY Revenue Growth % | +2.4% | -14.4% | — |
| Gross Profit | $560.6M | $563.8M | — |
| Gross Margin % | 37.8% | 39.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $193.7M | $210.0M | $324.7M |
| Operating Margin % | 13.1% | 14.5% | 19.2% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $250.0M | $241.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $169.2M | $224.7M | $320.7M |
| Capital Expenditures (CapEx) | $70.4M | $39.1M | — |
| Free Cash Flow (FCF) | $98.8M | $185.6M | $320.7M |
| FCF Margin % | 6.7% | 12.8% | 19.0% |
| Return on Invested Capital (ROIC %) | 18.6% | 16.6% | — |
| Cash & Short-Term Equivalents | $760.8M | $564.8M | — |
| Total Debt (Short + Long Term) | $448.0K | $0 | — |
| Total Stockholders' Equity | $1.59B | $1.57B | — |